BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38318261)

  • 1. Evaluation of Gabapentin and Pregabalin Use in Hospitalized Patients With Decreased Kidney Function.
    Knowles GM; LaFleur GE; Churchwell MD
    J Pharm Technol; 2024 Feb; 40(1):30-36. PubMed ID: 38318261
    [No Abstract]   [Full Text] [Related]  

  • 2. Higher-Dose Gabapentinoids and the Risk of Adverse Events in Older Adults With CKD: A Population-Based Cohort Study.
    Muanda FT; Weir MA; Ahmadi F; Sontrop JM; Cowan A; Fleet JL; Blake PG; Garg AX
    Am J Kidney Dis; 2022 Jul; 80(1):98-107.e1. PubMed ID: 34979160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabapentinoid Dosing and Associated Toxicities in Patients With or Without Concomitant Opioids During Hospitalization.
    Tu TG; Sadeghi S; Atayee R; Lee K
    Am J Hosp Palliat Care; 2022 May; 39(5):530-534. PubMed ID: 34409886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Gabapentin and Pregabalin Prescribing in a Tertiary Pediatric Medical Center.
    Donado C; Nedeljkovic K; Wangnamthip S; Solodiuk JC; Bourgeois FT; Berde CB
    Hosp Pediatr; 2021 Aug; 11(8):909-914. PubMed ID: 34257145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.
    Ibiloye EA; Barner JC; Lawson KA; Rascati KL; Evoy KE; Peckham AM
    Clin Drug Investig; 2021 Mar; 41(3):245-253. PubMed ID: 33580482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance.
    Tambon M; Ponté C; Jouanjus E; Fouilhé N; Micallef J; Lapeyre-Mestre M;
    Front Psychiatry; 2021; 12():639780. PubMed ID: 33613345
    [No Abstract]   [Full Text] [Related]  

  • 7. Concomitant Use of Gabapentinoids with Opioids Is Associated with Increased Mortality and Morbidity among Dialysis Patients.
    Waddy SP; Becerra AZ; Ward JB; Chan KE; Fwu CW; Eggers PW; Abbott KC; Kimmel PL
    Am J Nephrol; 2020; 51(6):424-432. PubMed ID: 32428902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample.
    Evoy KE; Covvey JR; Peckham AM; Reveles KR
    Int J Clin Pharm; 2021 Aug; 43(4):1055-1064. PubMed ID: 33387188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatalities associated with gabapentinoids in England (2004-2020).
    Kalk NJ; Chiu CT; Sadoughi R; Baho H; Williams BD; Taylor D; Copeland CS
    Br J Clin Pharmacol; 2022 Aug; 88(8):3911-3917. PubMed ID: 35435281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Outpatient Gabapentinoid Prescribing for Pain.
    Banks C; A Bowman L; Merrey J; Waldfogel JM
    J Pain Palliat Care Pharmacother; 2023 Jun; 37(2):143-147. PubMed ID: 36762999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between preoperative administration of gabapentinoids and 30-day hospital readmission: A retrospective hospital registry study.
    Wachtendorf LJ; Schaefer MS; Santer P; Azimaraghi O; Obeidat SS; Friedrich S; Zucco L; Woo A; Nabel S; Sundar E; Eikermann M; Ramachandran SK
    J Clin Anesth; 2021 Oct; 73():110376. PubMed ID: 34098392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentinoid Pharmacology in the Context of Emerging Misuse Liability.
    Evoy KE; Peckham AM; Covvey JR; Tidgewell KJ
    J Clin Pharmacol; 2021 Aug; 61 Suppl 2():S89-S99. PubMed ID: 34396549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-Dependent Association of Gabapentinoids with Pulmonary Complications After Total Hip and Knee Arthroplasties.
    Ohnuma T; Raghunathan K; Moore S; Setoguchi S; Ellis AR; Fuller M; Whittle J; Pyati S; Bryan WE; Pepin MJ; Bartz RR; Haines KL; Krishnamoorthy V
    J Bone Joint Surg Am; 2020 Feb; 102(3):221-229. PubMed ID: 31804238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of respiratory depression with opioids and concomitant gabapentinoids.
    Savelloni J; Gunter H; Lee KC; Hsu C; Yi C; Edmonds KP; Furnish T; Atayee RS
    J Pain Res; 2017; 10():2635-2641. PubMed ID: 29180889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Retrospective Analysis of Gabapentinoid and Opioids to Opioid Monotherapy for Pain Relief in Patients with Chronic Neck and Low Back Pain.
    Knezevic NN; Aijaz T; Camacho-Ortega A; Candido KD
    Pain Med; 2021 Aug; 22(8):1760-1766. PubMed ID: 33502505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
    Gore M; Sadosky A; Tai KS; Stacey B
    Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland.
    Torrance N; Veluchamy A; Zhou Y; Fletcher EH; Moir E; Hebert HL; Donnan PT; Watson J; Colvin LA; Smith BH
    Br J Anaesth; 2020 Aug; 125(2):159-167. PubMed ID: 32571568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update.
    Evoy KE; Sadrameli S; Contreras J; Covvey JR; Peckham AM; Morrison MD
    Drugs; 2021 Jan; 81(1):125-156. PubMed ID: 33215352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentinoids in Ireland 2010 to 2020: An observational study of trends in gabapentinoid prescribing, law enforcement drug seizures and postmortem toxicology.
    Durand L; O'Kane A; Tierney J; Cronly M; Bennett KE; Kavanagh Y; Keenan E; Cousins G
    Br J Clin Pharmacol; 2024 Apr; 90(4):987-995. PubMed ID: 38072974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin and gabapentin in non-opioid poisoning deaths.
    Kriikku P; Ojanperä I
    Forensic Sci Int; 2021 Jul; 324():110830. PubMed ID: 34000615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.